Malin Corporation plc (IR:MLC) — Market Cap & Net Worth
Market Cap & Net Worth: Malin Corporation plc (MLC)
Malin Corporation plc (IR:MLC) has a market capitalization of $35.40 Million (€30.28 Million) as of September 17, 2026. Listed on the IR stock exchange, this Ireland-based company holds position #23287 globally and #20 in its home market, demonstrating a 0.72% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Malin Corporation plc's stock price €7.00 by its total outstanding shares 4326168 (4.33 Million). Also see Malin Corporation plc assets under control for a full breakdown of the balance sheet.
Malin Corporation plc Market Cap History: 2015 to 2026
Malin Corporation plc's market capitalization history from 2015 to 2026. Data shows change from $53.66 Million to $35.40 Million (-3.66% CAGR). Also see Malin Corporation plc (MLC) cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
Malin Corporation plc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ISEQ 20 Price
IETP
|
$97.83 Billion | 0.04% | #16 of 19 |
|
ISEQ Overall
ISEQ
|
$99.32 Billion | 0.04% | #19 of 31 |
Weight: Malin Corporation plc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Malin Corporation plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Malin Corporation plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check MLC share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.51x
Malin Corporation plc's market cap is 0.51 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.24x
Malin Corporation plc's market cap is 0.24 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $53.66 Million | $22.90 Million | -$44.90 Million | 2.34x | N/A |
| 2016 | $61.70 Million | $42.10 Million | -$83.50 Million | 1.47x | N/A |
| 2017 | $42.99 Million | $41.90 Million | -$98.80 Million | 1.03x | N/A |
| 2018 | $25.29 Million | $38.00 Million | -$46.30 Million | 0.67x | N/A |
| 2019 | $22.96 Million | $34.90 Million | -$5.40 Million | 0.66x | N/A |
| 2020 | $20.74 Million | $41.00 Million | $87.70 Million | 0.51x | 0.24x |
Competitor Companies of MLC by Market Capitalization
Companies near Malin Corporation plc in the global market cap rankings as of September 17, 2026. Review how tangible is Malin Corporation plc's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Malin Corporation plc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #631 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #636 globally with a market cap of $43.34 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #672 globally with a market cap of $40.69 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #631 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #636 | GALDERMA GROUP AG | NYSE:GALDY | $43.34 Billion | $37.18 |
| #672 | Haleon plc | NYSE:HLN | $40.69 Billion | $9.24 |
Malin Corporation plc Historical Marketcap From 2015 to 2026
Between 2015 and today, Malin Corporation plc's market cap moved from $53.66 Million to $ 35.40 Million, with a yearly change of -3.66%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €35.40 Million | -9.09% |
| 2025 | €38.94 Million | -10.47% |
| 2024 | €43.50 Million | +91.11% |
| 2023 | €22.76 Million | -38.02% |
| 2022 | €36.72 Million | +8.36% |
| 2021 | €33.89 Million | +63.41% |
| 2020 | €20.74 Million | -9.69% |
| 2019 | €22.96 Million | -9.20% |
| 2018 | €25.29 Million | -41.18% |
| 2017 | €42.99 Million | -30.33% |
| 2016 | €61.70 Million | +14.99% |
| 2015 | €53.66 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Malin Corporation plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $35.40 Million USD |
| MoneyControl | $35.40 Million USD |
| MarketWatch | $35.40 Million USD |
| marketcap.company | $35.40 Million USD |
| Reuters | $35.40 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Malin Corporation plc
Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It also engages in investment activities. The company was incorporated in 2014 and is headquartered in Dublin, Ireland.